D3 Bio Investigative Site 0316

Chengdu, Sichuan 610041

1 studies enrolling now · 1 studies all time

What they study most

KRAS P.G12C

Studies at this site

• A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation — Recruiting now